-domide
Drugs related to thalidomide, used in myeloma and other cancers.
- Drugs ending in -domide: 12
- Approved somewhere: 3
- With a US drug page: 4
- Stem
- -domide
- Class
- Drugs related to thalidomide, used in myeloma and other cancers
- Most common targets
- CRL4(CRBN) E3 ubiquitin ligase (4)
Approved and clinical-stage drugs in ChEMBL whose names ending in -domide, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Lenalidomide | Approved | CRL4(CRBN) E3 ubiquitin ligase | CRL4(CRBN) E3 ubiquitin ligase inhibitor |
| Pomalidomide | Approved | CRL4(CRBN) E3 ubiquitin ligase | CRL4(CRBN) E3 ubiquitin ligase inhibitor |
| Thalidomide | Approved | CRL4(CRBN) E3 ubiquitin ligase | CRL4(CRBN) E3 ubiquitin ligase inhibitor |
| Iberdomide | Phase 3 | CRL4(CRBN) E3 ubiquitin ligase | CRL4(CRBN) E3 ubiquitin ligase modulator |
| Golcadomide | Phase 3 | — | — |
| Mezigdomide | Phase 3 | — | — |
| Avadomide | Phase 2 | — | — |
| Cemsidomide | Phase 2 | — | — |
| Sontigidomide | Phase 2 | — | — |
| Zomiradomide | Phase 2 | — | — |
| Eragidomide | Phase 1 | — | — |
| Zelebrudomide | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO